As many of you have likely seen, recent headlines about acetaminophen use during pregnancy and autism risk have generated significant controversy and confusion across the medical and scientific communities—leaving many expectant mothers understandably concerned.
The controversy centers on acetaminophen (commonly known as Tylenol or paracetamol) and claims that prenatal exposure may increase the risk of autism in children. The claims were quickly met with widespread criticism, but the inundation of conflicting messaging has understandably led to considerable confusion.
Our research team spends hundreds of hours each month vetting studies and distilling dense literature to deliver evidence-informed insights on health and longevity. If you find value in our work, consider becoming a premium member and supporting our mission.
In preparing our response for this week’s newsletter, it became clear that the topic demands a level of depth and nuance that extends beyond the scope of a brief written piece. Therefore, to give this subject the full attention it demands, and to never miss an opportunity to practice the skill of critical thought, we’ve decided instead to record a special podcast episode in which I will explain not only the isolated paper that largely prompted the recent announcement, but also the state of the evidence on autism and acetaminophen more broadly, as well as why research on the topics of autism and prenatal exposures can often be misleading.
Stay tuned for our release of this episode next week, Monday, October 6—a slight delay that we believe will result in richer and more comprehensive content.
For a list of all previous weekly emails, click here.
